Sign In

Mike Clayman

Independent Board Director

Mike Clayman is a highly accomplished individual with a strong educational background. He holds an MD in Medicine from UC San Diego School of Medicine and a BA in Molecular Biophysics and Biochemistry from Yale University.

Throughout his career, Mike Clayman has held several notable positions in various organizations. He has served as Chairman of the Board at Adipo Therapeutics, Nido Biosciences, Ribometrix, and Anokion. Additionally, he has been a Board Member at Anokion and Akebia Therapeutics. Mike has also showcased his leadership skills as the Co-Founder, CEO, and Director at Flexion Therapeutics.

With his extensive experience in the pharmaceutical and biotechnology sectors, Mike Clayman has also been associated with Eli Lilly in various roles such as Vice President of Lilly Research Laboratories, Global Regulatory Affairs, Cardiovascular Research and Clinical Investigation, Director of Clinical Pharmacology, and Clinical Research Physician. Furthermore, he has also worked as an Associate Clinical Research Physician at Eli Lilly and Company.

Mike Clayman's rich professional background highlights his expertise in leadership, pharmaceutical research, clinical investigations, regulatory affairs, and product development. His contributions to the industry have been significant and notable.

Highlights

Nov 19 · linkedin

I support Feeding America, and @Flexion Therapeutics supports me! I am proud to participate in Flexion’s #AttitudeofGratitude campaign by donating to an organization that is personally meaningful to me. In turn, Flexion is making a corporate donation on my behalf to Tunnel to Towers Foundation, a charity selected by the employees at Flexion.

https://lnkd.in/e-RX2QG

Jun 8 · linkedin

Interesting data

Mike Clayman
Add to my network

Location

Naples, Florida, United States